Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in Eur Thyroid J Retrieve available abstracts of 158 articles: HTML format

Single Articles

October 2025
1. JAGER EC, Sondorp LHJ, Maturi R, Antunes IF, et al
   Patient-derived medullary thyroid cancer organoids: a potential model for mechanistic studies on diagnostics and therapy.
   Eur Thyroid J. 2025;14:e240405.
   PubMed     Abstract available
   
   
   
2. VIRGINIA C, Antonio M, Valeria B, Alessandro P, et al
   Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy.
   Eur Thyroid J. 2025;14:e250074.
   PubMed     Abstract available
   
   
   
3. QUATTROCHI F, Grunenwald S, Caron P
   Apalutamide treatment and refractory hypothyroidism: effects of apalutamide on levothyroxine metabolism.
   Eur Thyroid J. 2025;14:e250185.
   PubMed     Abstract available
   
   
   
4. TOFT KRISTENSEN T, Plaschke CC, Fog Lomholt A, Holst Hahn C, et al
   Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer.
   Eur Thyroid J. 2025;14:e240282.
   PubMed     Abstract available
   
   
   
5. LEE ACH, Kahaly GJ
   Unravelling the pathogenic mechanisms in Graves' orbitopathy.
   Eur Thyroid J. 2025;14:e250200.
   PubMed     Abstract available
   
   
   
6. LI GH, Tang CM, Li RS, Ge GM, et al
   Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.
   Eur Thyroid J. 2025;14:e250220.
   PubMed     Abstract available
   
   
   August 2025
7. WANG J, Teng D, Yang K, Liu S, et al
   Long-term exposure to PM1 and thyroid diseases in China.
   Eur Thyroid J. 2025;14:e250106.
   PubMed     Abstract available
   
   
   
8. CERUTI D, Ottevanger PB, De Leo S, Bonenkamp HJ, et al
   Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies.
   Eur Thyroid J. 2025;14:e250161.
   PubMed     Abstract available
   
   
   
9. RIOS-MORRIS E, Tientcheu Ngaffi VI, Costagliola S, Romitti M, et al
   NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Development of 3D organoid models to study aggressive thyroid cancers.
   Eur Thyroid J. 2025;14:e240392.
   PubMed     Abstract available
   
   
   
10. TAPROGGE J, Murray I, Sharman H, Gape P, et al
    Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.
    Eur Thyroid J. 2025;14:e250097.
    PubMed     Abstract available
    
    
    
11. ZABLOTSKA LB, McConnell RJ, Rozhko AV, O'Kane P, et al
    Validation of established thyroid ultrasound volume norms in a Chernobyl cohort.
    Eur Thyroid J. 2025;14:e250085.
    PubMed     Abstract available
    
    
    
12. XU S, Peng Y, Li X, Li H, et al
    TSHR in thyroid cancer: bridging biological insights to targeted strategies.
    Eur Thyroid J. 2025;14:e240369.
    PubMed     Abstract available
    
    
    
13. TRIMBOLI P, Makovac P, Colombo A, Ruinelli L, et al
    Analysis of FNAC indication in thyroid nodules assessed as low risk according to various TIRADSs.
    Eur Thyroid J. 2025;14:e250113.
    PubMed     Abstract available
    
    
    
14. LUNDGAARD MH, Bruun NH, Andersen S, Andersen SL, et al
    Birth weight and placental weight in children born to mothers with hypothyroidism.
    Eur Thyroid J. 2025;14:e250111.
    PubMed     Abstract available
    
    
    
15. RYSKA A, Capdevila J, Dettmer MS, Elisei R, et al
    Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.
    Eur Thyroid J. 2025;14:e250024.
    PubMed     Abstract available
    
    
    
16. KASAHARA T
    The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study.
    Eur Thyroid J. 2025;14:e240388.
    PubMed     Abstract available
    
    
    
17. MEGIER C, Luton D, Stoupa A
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Management during pregnancy and long-term outcomes of adult patients with congenital hypothyroidism.
    Eur Thyroid J. 2025;14:e250125.
    PubMed     Abstract available
    
    
    
18. STAN MN, Dosiou C
    The evolving therapeutic landscape of Graves' disease in adults: present and future.
    Eur Thyroid J. 2025;14:e250078.
    PubMed     Abstract available
    
    
    
19. CENTANNI M, Duntas L, Feldt-Rasmussen U, Koehrle J, et al
    ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism.
    Eur Thyroid J. 2025;14:e250123.
    PubMed     Abstract available
    
    
    
20. KUHLEN M, Kunstreich M, Eilsberger F, Lorenz K, et al
    Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group.
    Eur Thyroid J. 2025;14:e250035.
    PubMed     Abstract available
    
    
    
21. VINCENZI G, Petralia IT, Abbate M, Vigone MC, et al
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Transient or permanent congenital hypothyroidism: from milestones to current and future perspectives.
    Eur Thyroid J. 2025;14:e250019.
    PubMed     Abstract available
    
    
    June 2025
22. KYRIACOU A, Vryza P, Kyriacou A, Picolos M, et al
    Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism.
    Eur Thyroid J. 2025;14:e240373.
    PubMed     Abstract available
    
    
    
23. GRIXTI L, Fisher H, Priestley J, McMullan C, et al
    Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey.
    Eur Thyroid J. 2025;14:e250044.
    PubMed     Abstract available
    
    
    
24. SESTI F, Feola T, Dolce P, Guarnotta V, et al
    Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis.
    Eur Thyroid J. 2025;14:e240347.
    PubMed     Abstract available
    
    
    
25. KARIMI AH, Zeng PY, Cecchini M, Barrett JW, et al
    NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.
    Eur Thyroid J. 2025;14:e250057.
    PubMed     Abstract available
    
    
    
26. PASCHKE R, Ghaznavi S, Imran SA, Jacquier J, et al
    Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada.
    Eur Thyroid J. 2025;14:e250072.
    PubMed     Abstract available
    
    
    
27. PIEKIELKO-WITKOWSKA A, Duda MK, Boguslawska J, Mackiewicz U, et al
    The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies.
    Eur Thyroid J. 2025;14:e240406.
    PubMed     Abstract available
    
    
    
28. MANSO J, Muller I, Mian C
    Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review.
    Eur Thyroid J. 2025;14:e250007.
    PubMed     Abstract available
    
    
    
29. CONDELLO V, Doerfler WR, Nikitski AV, Spagnolo DM, et al
    Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility.
    Eur Thyroid J. 2025;14:e250022.
    PubMed     Abstract available
    
    
    
30. LIU X, Cui L, Dong J, Ren J, et al
    Potential of bone marrow mesenchymal stem cells in iodine-induced autoimmune thyroiditis therapy.
    Eur Thyroid J. 2025;14:e240137.
    PubMed     Abstract available
    
    
    
31. NESET MT, Ulvik A, Lovas K, Laupsa-Borge J, et al
    Insight into the metabolic shifts in Graves' hyperthyroidism: a study of acylcarnitine and lipid profiles.
    Eur Thyroid J. 2025;14:e250004.
    PubMed     Abstract available
    
    
    
32. MORITANI S, Takenobu M, Yasunaga M, Fujii T, et al
    Usefulness of local therapy for distant metastases of differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240237.
    PubMed     Abstract available
    
    
    
33. COSTE J, Mandereau-Bruno L, Bertagna X, Wemeau JL, et al
    Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020.
    Eur Thyroid J. 2025;14:e250041.
    PubMed     Abstract available
    
    
    April 2025
34. GROB F, Lain S, Olivieri A
    Newborn screening for primary congenital hypothyroidism: past, present and future.
    Eur Thyroid J. 2025;14:e240358.
    PubMed     Abstract available
    
    
    
35. NYGAARD B, Jensen CZ, Jorsal M, Medici BR, et al
    Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms.
    Eur Thyroid J. 2025;14:e240275.
    PubMed     Abstract available
    
    
    
36. URKEN ML, Brandwein-Weber M, Chai RL, Zafereo M, et al
    An anatomic checklist for accurate staging of grossly invasive thyroid cancer.
    Eur Thyroid J. 2025;14:e240289.
    PubMed     Abstract available
    
    
    
37. LI T, Gui Y, Cui X, Wu X, et al
    Comparison of short-term outcomes following minimally invasive (endoscopic/robotic) vs open thyroidectomy for patients with thyroid cancer.
    Eur Thyroid J. 2025;14:e240134.
    PubMed     Abstract available
    
    
    
38. YAMAZAKI H, Sugino K, Inoue K, Katoh R, et al
    Analysis of immediate 503 thyroid carcinoma deaths: trend of single institution in 2005-2024.
    Eur Thyroid J. 2025;14:e240368.
    PubMed     Abstract available
    
    
    
39. EFFRAIMIDIS G, Sazakli E, Karapanou O, Saltiki K, et al
    Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change.
    Eur Thyroid J. 2025;14:e250013.
    PubMed     Abstract available
    
    
    
40. HIROMASA T, Wakabayashi H, Watanabe S, Yamase T, et al
    Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights.
    Eur Thyroid J. 2025;14:e240319.
    PubMed     Abstract available
    
    
    
41. DIEZ JJ, Galofre JC
    Management of benign nodular thyroid disease: a nationwide survey of endocrine specialists in Spain.
    Eur Thyroid J. 2025;14:e240313.
    PubMed     Abstract available
    
    
    
42. STOUPA A, Carre A, Polak M, Szinnai G, et al
    Genetics of primary congenital hypothyroidism: three decades of discoveries and persisting etiological challenges.
    Eur Thyroid J. 2025;14:e240348.
    PubMed     Abstract available
    
    
    
43. CHAUDHURY N, Crasto W, Saravanan P, Patel V, et al
    Intramuscular and subcutaneous levothyroxine: success in treating refractory hypothyroidism.
    Eur Thyroid J. 2025;14:e250012.
    PubMed     Abstract available
    
    
    
44. NOWAK A, Podlewski J, Hubalewska-Dydejczyk A, Trofimiuk-Muldner M, et al
    The impact of insulin resistance on thyroid function and the prevalence of thyroid follicular nodular disease in pregnant women.
    Eur Thyroid J. 2025;14:e240317.
    PubMed     Abstract available
    
    
    
45. ELOMAA K, Spick M, Gan EH, Pearce SH, et al
    Variable hyperthyroidism outcomes related to different treatment regimens: an analysis of UK Biobank data.
    Eur Thyroid J. 2025;14:e240393.
    PubMed     Abstract available
    
    
    
46. SMOLDERS A, Kyrilli A, Constantinescu SM, Corvilain B, et al
    High-dose versus low-dose block-and-replace treatment for a first episode of Graves' disease.
    Eur Thyroid J. 2025;14:e250039.
    PubMed     Abstract available
    
    
    
47. LUGARESI M, Moneta C, Saruggia G, Dionigi G, et al
    Changing the paradigm: lobectomy for sporadic medullary thyroid cancer.
    Eur Thyroid J. 2025;14:e250040.
    PubMed     Abstract available
    
    
    
48. KIYOTA N, Koyama T, Sugitani I
    Anticancer drug therapy for anaplastic thyroid cancer.
    Eur Thyroid J. 2025;14:e240287.
    PubMed     Abstract available
    
    
    
49. TAN J, Ge J, Wei Z, Sun B, et al
    Nomogram to predict the prognostic value of tumor deposits for patients with papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e240343.
    PubMed     Abstract available
    
    
    
50. MA Z, Mu R, Zhou Z, Hu Z, et al
    The mammalian acid chitinase promotes oncogenic properties of thyroid cancer cells through the JAK2/STAT3 pathway.
    Eur Thyroid J. 2025;14:e240311.
    PubMed     Abstract available
    
    
    
51. PULIANI G, Bianchini M, Giani C, Valerio L, et al
    Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).
    Eur Thyroid J. 2025;14:e240386.
    PubMed     Abstract available
    
    
    February 2025
52. ZHANG H, Wu S, Yang L, Fan C, et al
    Investigating factors influencing quality of life in thyroid eye disease: insight from machine learning approaches.
    Eur Thyroid J. 2025;14:e240292.
    PubMed     Abstract available
    
    
    
53. KIM MJ, Moon JH, Lee EK, Song YS, et al
    A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.
    Eur Thyroid J. 2025;14:e240281.
    PubMed     Abstract available
    
    
    
54. DEMETRIOU E, Economides A, Fokou M, Lamnisos D, et al
    Adiposity is associated with a higher number of thyroid nodules and worse fine-needle aspiration outcomes.
    Eur Thyroid J. 2025;14:e240176.
    PubMed     Abstract available
    
    
    
55. GRACA GM, Aguiar LR, De Lacerda L
    New diagnostic approach to central hypothyroidism after traumatic brain injury in children and adolescents.
    Eur Thyroid J. 2025;14:e240184.
    PubMed     Abstract available
    
    
    
56. POTONNIER W, Guillerm E, Bigorgne C, Ghander C, et al
    Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology.
    Eur Thyroid J. 2025;14:e240160.
    PubMed     Abstract available
    
    
    
57. YAMAUCHI I, Yabe D
    Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors.
    Eur Thyroid J. 2025;14:e240328.
    PubMed     Abstract available
    
    
    
58. LEE OW, Karyadi DM, Hartley SW, Zhou W, et al
    Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e240235.
    PubMed     Abstract available
    
    
    
59. PORCELLI T, Luongo C, Cerbone A, Di Luccio C, et al
    Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
    Eur Thyroid J. 2025;14:e240332.
    PubMed     Abstract available
    
    
    
60. CARDO C, Bernardo Santos R, Pinotti Pedro Miklos AB, Barbosa Jaconis S, et al
    The relationship between cholesterol levels and thyroid eye disease.
    Eur Thyroid J. 2025;14:e240133.
    PubMed     Abstract available
    
    
    
61. ARRIGONI M, Zwaveling-Soonawala N, LaFranchi SH, van Trotsenburg ASP, et al
    Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start.
    Eur Thyroid J. 2025;14:e240327.
    PubMed     Abstract available
    
    
    
62. PICCARDO A, Fiz F, Righi S, Raffa S, et al
    [18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240320.
    PubMed     Abstract available
    
    
    
63. LIU M, Tang J, Sun N, Xi C, et al
    Pleural metastases from differentiated thyroid cancer: clinical features and long-term outcomes.
    Eur Thyroid J. 2025;14:e240147.
    PubMed     Abstract available
    
    
    
64. DUTTA S, Knauf JA
    Development of animal models to study aggressive thyroid cancers.
    Eur Thyroid J. 2025;14:e240361.
    PubMed     Abstract available
    
    
    
65. BOELEN A, Heijboer AC
    Newborn screening and the screening laboratory: past, present and future.
    Eur Thyroid J. 2025;14:e240325.
    PubMed     Abstract available
    
    
    
66. VALDERRABANO P, Quinones Silva JB, Campos Mena S, Familiar Casado C, et al
    Evaluation of thyroid ultrasound reports' quality in the Community of Madrid, Spain.
    Eur Thyroid J. 2025;14:e240390.
    PubMed     Abstract available
    
    
    
67. GARRELFS MR, Mooij CF, Boelen A, van Trotsenburg ASP, et al
    Newborn screening for central congenital hypothyroidism: past, present and future.
    Eur Thyroid J. 2025;14:e240329.
    PubMed     Abstract available
    
    
    
68. PRASAI M, Lomre M, Jelloul E, Kleynen P, et al
    Higher prevalence of gestational diabetes in euthyroid women with thyroid autoimmunity who were expecting a female fetus.
    Eur Thyroid J. 2025;14:e240339.
    PubMed     Abstract available
    
    
    
69. KUHLEN M, Kunstreich M, Eilsberger F, Luster M, et al
    Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis.
    Eur Thyroid J. 2025;14:e240341.
    PubMed     Abstract available
    
    
    December 2024
70. RUCZ K, Hegedus L, Bonnema SJ, Frasoldati A, et al
    Echogenicity as a standalone nodule characteristic is not inferior to the TIRADS systems in the 10-20 mm nodule diameter range in patient selection for fine needle aspiration: a pilot study.
    Eur Thyroid J. 2024;13:e240149.
    PubMed     Abstract available
    
    
    
71. MARINO M, Rotondo Dottore G, Menconi F, Comi S, et al
    Role of genetics and epigenetics in Graves' orbitopathy.
    Eur Thyroid J. 2024;13:e240179.
    PubMed     Abstract available
    
    
    
72. PAUL J, Joseph A, Jebasingh F, More AR, et al
    Thyrotoxic periodic paralysis - a retrospective study from Southern India.
    Eur Thyroid J. 2024;13:e240164.
    PubMed     Abstract available
    
    
    
73. CARLQVIST J, Nyman U, Brandberg J, Nystrom HF, et al
    Effects of iodine contrast media on thyroid function - a prospective study.
    Eur Thyroid J. 2024;13:e240244.
    PubMed     Abstract available
    
    
    
74. FUJIKAWA M, Okamura K
    Graves' hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up.
    Eur Thyroid J. 2024;13:e240085.
    PubMed     Abstract available
    
    
    
75. ELGHAWY O, Barsouk A, Xu J, Chen S, et al
    Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240225.
    PubMed     Abstract available
    
    
    
76. CONDELLO V, Juhlin CC
    MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?
    Eur Thyroid J. 2024;13:e240298.
    PubMed     Abstract available
    
    
    October 2024
77. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    PubMed     Abstract available
    
    
    
78. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    PubMed     Abstract available
    
    
    
79. GAMBALE C, Prete A, Romei C, Celi A, et al
    Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.
    Eur Thyroid J. 2024;13:e240189.
    PubMed     Abstract available
    
    
    
80. ITO Y, Miyauchi A
    Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.
    Eur Thyroid J. 2024;13:e240196.
    PubMed     Abstract available
    
    
    
81. PARK H, Heo J, Ryu HJ, Kim MJ, et al
    The association between BMI and BRAFV600E mutation may differ by primary tumor size.
    Eur Thyroid J. 2024;13:e230255.
    PubMed     Abstract available
    
    
    
82. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Management of follicular thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240146.
    PubMed     Abstract available
    
    
    
83. DAVID K, Van Crombrugge P, Van der Biest AM, D'Hondt F, et al
    Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid management.
    Eur Thyroid J. 2024;13:e240158.
    PubMed     Abstract available
    
    
    
84. TSYBROVSKYY O, Sobrinho-Simoes M, Tallini G
    'Incidental thyroid cancer' is not synonymous with 'overdiagnosis'.
    Eur Thyroid J. 2024;13:e240283.
    PubMed    
    
    
    
85. COSME I, Figueiredo A, Pinheiro S, Leite V, et al
    Incidental thyroid cancer and overdiagnosis: response to Drs Tsybrovskyy, Sobrinho-Simoes, and Tallini.
    Eur Thyroid J. 2024;13:e240296.
    PubMed    
    
    
    
86. IMAI H, Watanabe N, Hirose R, Koshibu M, et al
    Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.
    Eur Thyroid J. 2024;13:e240128.
    PubMed     Abstract available
    
    
    
87. ZHAO C, Sun Z, Wang S, Zhang J, et al
    IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.
    Eur Thyroid J. 2024;13:e240156.
    PubMed     Abstract available
    
    
    August 2024
88. LAI KKH, Aljufairi FMAA, Sebastian JU, Wei Y, et al
    Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.
    Eur Thyroid J. 2024;13:e230129.
    PubMed     Abstract available
    
    
    
89. CHUNG CW, Kim K, Park SK, Ju DL, et al
    Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.
    Eur Thyroid J. 2024;13:e240007.
    PubMed     Abstract available
    
    
    
90. ZHANG Z, Yu J, Rainer E, Hargitai L, et al
    The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.
    Eur Thyroid J. 2024;13:e240089.
    PubMed     Abstract available
    
    
    
91. BARAN JA, Bojarsky M, Halada S, Ricarte-Filho JC, et al
    Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection.
    Eur Thyroid J. 2024;13:e230265.
    PubMed     Abstract available
    
    
    
92. LEONCINI A, Camponovo C, Paone G, Gamarra E, et al
    Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible.
    Eur Thyroid J. 2024;13:e240123.
    PubMed     Abstract available
    
    
    
93. MINALDI E, Cappagli V, Lorusso L, Valerio L, et al
    Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.
    Eur Thyroid J. 2024;13:e240009.
    PubMed     Abstract available
    
    
    
94. PERSANI L, Rodien P, Moran C, Edward Visser W, et al
    2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
    Eur Thyroid J. 2024;13:e240125.
    PubMed     Abstract available
    
    
    
95. HECHT F, Valerio L, Goncalves CFL, Harinquet M, et al
    A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.
    Eur Thyroid J. 2024;13:e240028.
    PubMed     Abstract available
    
    
    
96. VAN HOUTEN P, Nagarajah J, Walraven JEW, Jaeger M, et al
    Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240153.
    PubMed     Abstract available
    
    
    
97. ZHANG H, Wu S, Hu S, Fan X, et al
    Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease.
    Eur Thyroid J. 2024;13:e240122.
    PubMed     Abstract available
    
    
    June 2024
98. COLOMBO C, Ceruti D, Succi M, De Leo S, et al
    Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
    Eur Thyroid J. 2024;13:e230246.
    PubMed     Abstract available
    
    
    
99. SYED AR, Gorana A, Nohr E, Yuan XK, et al
    Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
    Eur Thyroid J. 2024;13:e230227.
    PubMed     Abstract available
    
    
    
100. FUGAZZOLA L, Deandrea M, Borgato S, Dell'Acqua M, et al
     Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
     Eur Thyroid J. 2024;13:e240020.
     PubMed     Abstract available
     
     
     
101. CIRELLO V, Lugaresi M, Moneta C, Dufour P, et al
     Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
     Eur Thyroid J. 2024;13:e230192.
     PubMed     Abstract available
     
     
     
102. TANG MOLLEHAVE L, Knudsen N, Linneberg A, Bulow Pedersen I, et al
     The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications.
     Eur Thyroid J. 2024;13:e230230.
     PubMed     Abstract available
     
     
     
103. CHEN J, Li C, Teng W, Shan Z, et al
     A Chinese survey of clinical practice on the management of thyroid eye disease.
     Eur Thyroid J. 2024;13:e230269.
     PubMed     Abstract available
     
     
     
104. MAVROMATI M, Caironi V, Saiji E, Vargas MI, et al
     Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology.
     Eur Thyroid J. 2024;13:e240011.
     PubMed     Abstract available
     
     
     
105. URSEM SR, Boelen A, Bruinstroop E, Elders PJM, et al
     A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations.
     Eur Thyroid J. 2024;13:e240036.
     PubMed     Abstract available
     
     
     
106. DEMARTIN S, Constantinescu SM, Poppe KG, Maiter D, et al
     Long-term hypothyroidism in patients started on levothyroxine during pregnancy.
     Eur Thyroid J. 2024;13:e240051.
     PubMed     Abstract available
     
     
     
107. DE VINCENTIS S, Loiacono S, Zanni E, Sueri R, et al
     Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.
     Eur Thyroid J. 2024;13:e240083.
     PubMed     Abstract available
     
     
     April 2024
108. BARRETO MCA, Treistman N, Cavalcante LBCP, Bulzico D, et al
     Serum anti-Mullerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
     Eur Thyroid J. 2024;13:e230252.
     PubMed     Abstract available
     
     
     
109. PITICCHIO T, Russ G, Radzina M, Frasca F, et al
     Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: systematic review and meta-analysis.
     Eur Thyroid J. 2024;13:e230242.
     PubMed     Abstract available
     
     
     
110. KOSTOPOULOS G, Effraimidis G
     Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.
     Eur Thyroid J. 2024;13:e230254.
     PubMed     Abstract available
     
     
     
111. RIIS T, Bonnema SJ, Brix TH, Folkestad L, et al
     Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
     Eur Thyroid J. 2024;13:e230181.
     PubMed     Abstract available
     
     
     
112. MULLER I, Maioli S, Armenti M, Porcaro L, et al
     Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
     Eur Thyroid J. 2024;13:e230236.
     PubMed     Abstract available
     
     
     
113. JU SH, Ji YB, Song M, Lim JY, et al
     Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma
     Eur Thyroid J. 2024;13:e230258.
     PubMed     Abstract available
     
     
     
114. CROCE L, Beneventi F, Ripepi F, De Maggio I, et al
     Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.
     Eur Thyroid J. 2024;13:e230213.
     PubMed     Abstract available
     
     
     February 2024
115. HOU S, Sun Y, Yang Z, Tang M, et al
     The diagnostic value of GICA used for intraoperative lymph node FNA-Tg measurement to evaluate thyroid cancer metastases.
     Eur Thyroid J. 2024;13:e230182.
     PubMed     Abstract available
     
     
     
116. HOLMBERG M, Malmgren H, Berglund PF, Johansson B, et al
     Psychiatric complications in Graves' disease.
     Eur Thyroid J. 2024;13:e230247.
     PubMed     Abstract available
     
     
     
117. GIANOUKAKIS AG, Choe JH, Bowles DW, Brose MS, et al
     Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
     Eur Thyroid J. 2024;13:e230039.
     PubMed     Abstract available
     
     
     
118. ZHANG H, Hu H, Wang Y, Duan X, et al
     Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
     Eur Thyroid J. 2024;13:e230109.
     PubMed     Abstract available
     
     
     December 2023
119. MAVROMATI M, Saiji E, Demarchi MS, Lenoir V, et al
     Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
     Eur Thyroid J. 2023;12:e230114.
     PubMed     Abstract available
     
     
     
120. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
     Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
     Eur Thyroid J. 2023;12:e230105.
     PubMed     Abstract available
     
     
     
121. GAMBALE C, Prete A, Contartese L, Torregrossa L, et al
     Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
     Eur Thyroid J. 2023;12:e230052.
     PubMed     Abstract available
     
     
     
122. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
     Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
     Eur Thyroid J. 2023;12:e230049.
     PubMed     Abstract available
     
     
     
123. JANSEN HI, van Haeringen M, Bouva MJ, den Elzen WPJ, et al
     Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
     Eur Thyroid J. 2023;12:e230141.
     PubMed     Abstract available
     
     
     
124. WU L, Vaccarella S, Feng CY, Dal Maso L, et al
     Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
     Eur Thyroid J. 2023;12:e230127.
     PubMed     Abstract available
     
     
     
125. RIIS KR, Larsen CB, Medici BR, Jensen CZ, et al
     Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
     Eur Thyroid J. 2023;12:e230167.
     PubMed     Abstract available
     
     
     
126. WAN Z, Li Y, Dong X, Kang Y, et al
     Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study.
     Eur Thyroid J. 2023;12:e230168.
     PubMed     Abstract available
     
     
     
127. CONSTANTINESCU SM, Hospel J, Daumerie C, Alexopoulou O, et al
     Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves' disease.
     Eur Thyroid J. 2023;12:e230193.
     PubMed     Abstract available
     
     
     
128. TSENG HH, Lin YB, Lin KY, Lin CH, et al
     A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
     Eur Thyroid J. 2023;12:e230162.
     PubMed     Abstract available
     
     
     
129. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
     Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
     Eur Thyroid J. 2023;12:e230049.
     PubMed     Abstract available
     
     
     
130. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
     Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
     Eur Thyroid J. 2023;12:e230105.
     PubMed     Abstract available
     
     
     
131. KYRILLI A, Tacelli N, Russo L, Lebrun L, et al
     Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
     Eur Thyroid J. 2023;12:e230135.
     PubMed     Abstract available
     
     
     
132. LEE YJ, Choi YH, Lim YH, Kim BN, et al
     Effects of iodine status on thyroid volume and goiter in children living in an iodine-replete area.
     Eur Thyroid J. 2023;12:e230219.
     PubMed     Abstract available
     
     
     
133. HUSTED L, Rodgaard-Hansen S, Lundgaard MH, Uldall Torp NM, et al
     Biochemical markers of renal function and maternal hypothyroidism in early pregnancy.
     Eur Thyroid J. 2023;12:e230157.
     PubMed     Abstract available
     
     
     
134. WON HR, Kim MG, Kim MS, Chang JW, et al
     Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
     Eur Thyroid J. 2023;12:e230195.
     PubMed     Abstract available
     
     
     
135. BAHCECIOGLU AB, Gursoy A, Dizbay Sak S, Ilgan S, et al
     The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.
     Eur Thyroid J. 2023;12:e230108.
     PubMed     Abstract available
     
     
     
136. JIA HY, Chen J, Zhai ZX, Fan WW, et al
     Characterization of thyroid metastasis from clear cell renal cell carcinoma on ultrasonography: a report of three cases and literature review.
     Eur Thyroid J. 2023;12:e230121.
     PubMed     Abstract available
     
     
     October 2023
137. DURANTE C, Hegedus L, Czarniecka A, Paschke R, et al
     2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
     Eur Thyroid J. 2023;12:e230067.
     PubMed     Abstract available
     
     
     
138. PINAR-GUTIERREZ A, Romero-Lluch AR, Duenas-Disotuar S, de Lara-Rodriguez I, et al
     Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
     Eur Thyroid J. 2023;12:e230086.
     PubMed     Abstract available
     
     
     
139. FU J, Fan Z, He L, Liu Q, et al
     Circadian clock disruption in autoimmune thyroiditis.
     Eur Thyroid J. 2023;12:e230035.
     PubMed     Abstract available
     
     
     
140. URSEM SR, Boelen A, Hillebrand JJ, den Elzen WPJ, et al
     How low can we (reliably) go? A method comparison of thyroid-stimulating hormone assays with a focus on low concentrations.
     Eur Thyroid J. 2023;12:e230123.
     PubMed     Abstract available
     
     
     
141. MANSO J, Censi S, Clausi C, Piva I, et al
     Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.
     Eur Thyroid J. 2023;12:e230083.
     PubMed     Abstract available
     
     
     August 2023
142. WU J, Hu X, Seal P, Amin P, et al
     Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
     Eur Thyroid J. 2023;12:e230110.
     PubMed     Abstract available
     
     
     
143. HALENKA M, Munteanu H, Obereigneru R, Dohnal R, et al
     Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
     Eur Thyroid J. 2023;12:e230085.
     PubMed     Abstract available
     
     
     
144. SOLDEVILA B, Velasco I, Munoz C, Diaz Y, et al
     Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
     Eur Thyroid J. 2023;12:e230016.
     PubMed     Abstract available
     
     
     
145. CAPDEVILA J, Deandreis D, Durante C, Leboulleux S, et al
     Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
     Eur Thyroid J. 2023;12:e230068.
     PubMed     Abstract available
     
     
     
146. CAMPI I, Dell'Acqua M, Stellaria Grassi E, Cristina Vigone M, et al
     Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart.
     Eur Thyroid J. 2023;12:e230012.
     PubMed     Abstract available
     
     
     
147. PERROS P, Hegedus L
     Teprotumumab in thyroid eye disease: wonder drug or great divider?
     Eur Thyroid J. 2023;12:e230043.
     PubMed     Abstract available
     
     
     
148. JU N, Hou L, Song H, Qiu Z, et al
     TSH >/=30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
     Eur Thyroid J. 2023;12:e220219.
     PubMed     Abstract available
     
     
     July 2023
149. NILSSON JN, Siikanen J, Condello V, Jatta K, et al
     Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
     Eur Thyroid J. 2023;12:e230099.
     PubMed     Abstract available
     
     
     
150. MO C, Chen H, Zhang Q, Guo Y, et al
     Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
     Eur Thyroid J. 2023;12:e220223.
     PubMed     Abstract available
     
     
     
151. BENABDELKAMEL H, Jaber MA, Dahabiyeh LA, Masood A, et al
     Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
     Eur Thyroid J. 2023;12:e230062.
     PubMed     Abstract available
     
     
     
152. BOELEN A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP, et al
     Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
     Eur Thyroid J. 2023;12:e230041.
     PubMed     Abstract available
     
     
     
153. DAL MASO L, Pierannunzio D, Francisci S, De Paoli A, et al
     Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
     Eur Thyroid J. 2023;12:e230051.
     PubMed     Abstract available
     
     
     
154. SOARES MN, Borges-Canha M, Neves C, Neves JS, et al
     The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
     Eur Thyroid J. 2023;12:e230055.
     PubMed     Abstract available
     
     
     
155. JOHANSSON B, Holmberg M, Skau S, Malmgren H, et al
     The relationship between mental fatigue, depression, and cognition in Graves' disease.
     Eur Thyroid J. 2023;12:e230040.
     PubMed     Abstract available
     
     
     
156. COLOMBO C, Ceruti D, De Leo S, Bilo G, et al
     Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
     Eur Thyroid J. 2023;12:e230047.
     PubMed     Abstract available
     
     
     June 2023
157. DIAS D, Damasio I, Marques P, Simoes H, et al
     Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
     Eur Thyroid J. 2023;12:e220227.
     PubMed     Abstract available
     
     
     
158. KARA C, Mammadova J, Abur U, Gumuskaptan C, et al
     Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism.
     Eur Thyroid J. 2023;12:e220212.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.